{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"6.100","floor":"4.600"},"ipodate":{"start":"2010-09-13 00:00:00","end":"2010-09-16 00:00:00"},"minimumcapital":"6161.49","subscribed":"225.27","marketcap":"85.94億","H_marketcap":"--","pe":"3.42","codesrate":"50.00","link":"https://www1.hkexnews.hk/listedco/listconews/sehk/2010/0913/ltn20100913006_c.htm","ipopricing":"6.100","resultdate":"2010-09-23 00:00:00","enddate":"2010-09-16 00:00:00","listeddate":"2010-09-24 00:00:00","issuenumber":"25274.00萬","issuenumberhK":"12637.00萬","issuenumberother":"12637.00萬","grayprice":"--","sponsors":"瑞士信貸(香港)有限公司,派杰亞洲有限公司","raisemoney":"142830.00萬","use":"1、約50%或714.1百萬港元，用于擴大本集團的產品系列；\n2、約25%或357.1百萬港元，用于擴充本集團的生產設施；\n3、約20%或285.7百萬港元，用于擴大本集團在中國和世界各地；\n4、約5%或71.4百萬港元，用于營運資金及為其他一般企業用途提供資金。","shares":1000,"leadagent":"瑞士信貸(香港)有限公司,派杰亞洲證券有限公司","bookrunners":"瑞士信貸(香港)有限公司,派杰亞洲證券有限公司","coordinator":"瑞士信貸(香港)有限公司","firstDayOpen":"7.25","IsEiio":0,"Interestdays":7,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"瑞士信貸(香港)有限公司","code":"E00853","name":"微創醫療","fullname":"微創醫療科學有限公司"},"institutioninfo":{"principaloffice":"中國上海張江高科技園區張東路1601號","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"常兆華","secretary":"袁頴欣","telephone":"(8621) 3895 4600","substantialshareholders":"Otsuka Pharmaceutical Co.,Ltd.(23.89%),Maxwell Maxcare Science Foundation Limited(14.62%),Shanghai ZJ Hi-Tech Investment Corporation(13.83%),Erudite Holdings Limited(9.95%),新加坡政府投資有限公司(8.44%)","principalactivities":"於中國開發、制造及營銷醫療器械，主要專注於治療血管疾病及病變的微創介入產品。","website":"http://www.microport.com.cn"},"managerinfo":[],"investorinfo":[],"TotalShareholdingPercentage":0},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":516}